News
U.S. FDA approves Pfizer’s BEQVEZ for adults with hemophilia B
The U.S. Food and Drug Administration (FDA) has approved Pfizer's BEQVEZ (fidanacogene elaparvovec-dzkt) for the treatment of adults with moderate to severe hemophilia B...
AskBio receives FDA Fast Track Designation for investigational gene therapy program in congestive heart...
Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has been...
Genomics plc and GSK establish precision medicine collaboration
Genomics plc and GSK have established a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve...
